ROR1 and neoplasm: While the efficacy of CAR-T in solid tumor remained a challenge, our ROR1 Hinge CAR-T-cells significantly suppressed tumor growth compared to the control groups in different solid tumor xenograft models, suggesting the ROR1 Hinge CAR is also effective against different types of solid tumors.